Article
Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
The Journal of rheumatology - 1 Nov 2011
Mjaavatten Maria D, van der Heijde Désirée M, Uhlig Till, Haugen Anne J, Nygaard Halvor, Bjørneboe Olav, Kvien Tore K
Abstract excerpt
OBJECTIVE: Presence and levels of antibodies contribute to the classification of rheumatoid arthritis. We investigated the longitudinal course of anti-citrullinated protein antibodies (ACPA) and immunoglobin M (IgM) rheumatoid factor (RF) during the first year after arthritis onset in patients with very short disease duration. METHODS: Patients (aged 18-75 years) with ≥ 1 swollen joint of ≤ 16 weeks' duration had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
